Baxter International, Inc.

Baxter International, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Baxter International, Inc. is a healthcare company that produces devices and equipment. Its products help medical professionals provide nutritional care, kidney care, and respiratory care in addition to general healthcare.

Ticker: BAX

Humankind Value: $74.7 B

Revenue: $12.1 B

Market Cap: $35.8 B

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Medical device research and development is responsible for substantive gains in length and quality of life. Baxter International, Inc. has earned a spot in our top 100, with much of its positive value coming from Medical Devices ($50.6 B), Healthcare R&D ($9.5 B), and Pharmaceuticals ($8.6 B). The value associated with Medical Devices, Healthcare R&D, and Pharmaceuticals is linked to an estimate of 1,425,297.8 additional years lived by people worldwide. However, there is room for improvement with respect to Greenhouse Gases (-$554.1 M) and Opioid Abuse (-$341.3 M). Medical Devices, Healthcare R&D, and Pharmaceuticals are attached to this company as a result of its direct business activities. Greenhouse Gases and Opioid Abuse are mostly or entirely a result of supply-chain relationships.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

How Methodology Drives the Rankings